Northern Trust
EPIX

Northern Trust’s ESSA Pharma EPIX Stock Holding History

Northern Trust’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,489
Closed -$33.7K – 4490
2023
Q2 		$33.7K Hold
12,489
– – ﹤0.01% 4306
2023
Q1 		$37.1K Buy
12,489
+761
+6% +$2.24K ﹤0.01% 4329
2022
Q4 		$29.6K Sell
11,728
-140
-1% -$402 ﹤0.01% 4400
2022
Q3 		$22K Buy
11,868
+199
+2% +$524 ﹤0.01% 4527
2022
Q2 		$37K Sell
11,669
-13,275
-53% -$74.2K ﹤0.01% 4487
2022
Q1 		$154K Sell
24,944
-615
-2% -$5.41K ﹤0.01% 4216
2021
Q4 		$363K Buy
25,559
+4,102
+19% +$45.7K ﹤0.01% 3929
2021
Q3 		$172K Sell
21,457
-7,500
-26% -$119K ﹤0.01% 4240
2021
Q2 		$827K Buy
28,957
+16,904
+140% +$491K ﹤0.01% 3576
2021
Q1 		$350K Buy
+12,053
New +$280K ﹤0.01% 3923

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Northern Trust's EPIX Position: Q3 2023 in Review

Northern Trust sold out of ESSA Pharma (EPIX) in Q3 2023, closing a stake of 12,489 shares — an estimated $33.7K sold.

Northern Trust first reported a position in EPIX in Q1 2021 and held it in 10 quarters. The position peaked at $827K in Q2 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q3 2023.

  • Northern Trust reported no remaining ESSA Pharma position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 12,489 ESSA Pharma shares in Q3 2023, an estimated $33.7K.
  • Northern Trust first reported a position in ESSA Pharma in Q1 2021 and held it in 10 quarters.
  • Northern Trust's ESSA Pharma position peaked at $827K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.